These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 30176494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
    Jarrett RB, Thase ME.
    Contemp Clin Trials; 2010 Jul; 31(4):355-77. PubMed ID: 20451668
    [Abstract] [Full Text] [Related]

  • 4. Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Psychotherapy (Chic); 2015 Jun; 52(2):268-77. PubMed ID: 25985046
    [Abstract] [Full Text] [Related]

  • 5. Quality of life after response to acute-phase cognitive therapy for recurrent depression.
    Vittengl JR, Jha MK, Minhajuddin A, Thase ME, Jarrett RB.
    J Affect Disord; 2021 Jan 01; 278():218-225. PubMed ID: 32971314
    [Abstract] [Full Text] [Related]

  • 6. Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Consult Clin Psychol; 2014 Dec 01; 82(6):1049-59. PubMed ID: 25045908
    [Abstract] [Full Text] [Related]

  • 7. Cognitive therapy for depressed adults with comorbid social phobia.
    Smits JA, Minhajuddin A, Jarrett RB.
    J Affect Disord; 2009 Apr 01; 114(1-3):271-8. PubMed ID: 18804285
    [Abstract] [Full Text] [Related]

  • 8. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.
    J Psychopharmacol; 2002 Sep 01; 16(3):215-9. PubMed ID: 12236627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Anna Clark L, Thase ME, Jarrett RB.
    Psychiatry Res; 2017 Jul 01; 253():174-181. PubMed ID: 28388454
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.
    Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME.
    JAMA Psychiatry; 2013 Nov 01; 70(11):1152-60. PubMed ID: 24005123
    [Abstract] [Full Text] [Related]

  • 13. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR, Bukstein OG, Douaihy AB, Clark DB, Chung TA, Daley DC, Wood DS, Brown SJ.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):39-45. PubMed ID: 20576364
    [Abstract] [Full Text] [Related]

  • 14. The influence of comorbid anxiety on the effectiveness of Cognitive Therapy and Interpersonal Psychotherapy for Major Depressive Disorder.
    van Bronswijk SC, Lemmens LHJM, Huibers MJH, Arntz A, Peeters FPML.
    J Affect Disord; 2018 May 01; 232():52-60. PubMed ID: 29477584
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Behav Ther; 2019 Jul 01; 50(4):765-777. PubMed ID: 31208686
    [Abstract] [Full Text] [Related]

  • 17. Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing care.
    Jarrett RB, Minhajuddin A, Vittengl JR, Clark LA, Thase ME.
    J Consult Clin Psychol; 2016 Apr 01; 84(4):365-76. PubMed ID: 26654211
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationships between major depressive disorder and comorbid anxiety and personality disorders.
    Farabaugh A, Fava M, Mischoulon D, Sklarsky K, Petersen T, Alpert J.
    Compr Psychiatry; 2005 Apr 01; 46(4):266-71. PubMed ID: 16175757
    [Abstract] [Full Text] [Related]

  • 20. Defined symptom-change trajectories during acute-phase cognitive therapy for depression predict better longitudinal outcomes.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Behav Res Ther; 2016 Dec 01; 87():48-57. PubMed ID: 27591917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.